Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMBRISENTAN Cause Cardiac failure congestive? 1,359 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 1,359 reports of Cardiac failure congestive have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 1.6% of all adverse event reports for AMBRISENTAN.

1,359
Reports of Cardiac failure congestive with AMBRISENTAN
1.6%
of all AMBRISENTAN reports
174
Deaths
1,084
Hospitalizations

How Dangerous Is Cardiac failure congestive From AMBRISENTAN?

Of the 1,359 reports, 174 (12.8%) resulted in death, 1,084 (79.8%) required hospitalization, and 13 (1.0%) were considered life-threatening.

Is Cardiac failure congestive Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 1,359 reports have been filed with the FAERS database.

What Other Side Effects Does AMBRISENTAN Cause?

Dyspnoea (13,367) Death (7,497) Headache (7,325) Pneumonia (4,693) Dizziness (4,561) Fatigue (4,436) Diarrhoea (4,312) Nausea (3,986) Fluid retention (3,927) Malaise (3,839)

What Other Drugs Cause Cardiac failure congestive?

ROSIGLITAZONE (15,085) METFORMIN\ROSIGLITAZONE (1,408) LENALIDOMIDE (1,373) SACUBITRIL\VALSARTAN (1,355) APIXABAN (1,144) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (1,129) AVANDIA (1,102) ADALIMUMAB (990) MACITENTAN (979) TREPROSTINIL (955)

Which AMBRISENTAN Alternatives Have Lower Cardiac failure congestive Risk?

AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN AMBRISENTAN vs AMBROXOL AMBRISENTAN vs AMDINOCILLIN PIVOXIL AMBRISENTAN vs AMG-510 AMBRISENTAN vs AMIFAMPRIDINE

Related Pages

AMBRISENTAN Full Profile All Cardiac failure congestive Reports All Drugs Causing Cardiac failure congestive AMBRISENTAN Demographics